| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $170.4M | -7.7% |
| R&D Expense | $81.6M | +7.0% |
| SG&A Expense | $294.1M | +9.2% |
| Operating Income | -$73.4M | -183.7% |
| Interest Expense | $16.6M | -18.4% |
| Pre-tax Income | -$63.1M | -202.3% |
| Income Tax | $36.5M | +84.6% |
| Net Income | -$99.6M | -337.3% |
| EPS (Basic) | -$2.15 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $276.8M | +80.5% |
| Short-term Investments | $207.8M | +65.9% |
| Accounts Receivable | $113.3M | +7.3% |
| Inventory | $125.3M | +20.1% |
| Current Assets | $745.1M | +46.1% |
| Total Assets | $1.55B | -1.3% |
| Current Liabilities | $309.9M | +218.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $189.4M | +22.5% |
| Capital Expenditures | $10.6M | -29.8% |
| Investing Cash Flow | -$83.3M | -207.4% |
| Financing Cash Flow | $17.4M | +109.5% |
| Free Cash Flow | $178.8M | +28.1% |
| -336.3% |
| EPS (Diluted) | -$2.15 | -341.6% |
| Long-term Debt |
| $585.3M |
| +12.0% |
| Total Liabilities | $775.2M | +10.1% |
| Stockholders' Equity | $778.3M | -10.5% |